Skip to main content
Equibles

StoneX Group Inc.

Position in PCSA — Processa Pharmaceuticals, Inc.

CIK 913760 New York, NY
Back to PCSA Full portfolio

Position in PCSA

as of Jun 30, 2026 · filed Aug 12, 2026
Position Value
$21,959
+$18,321 QoQ
Shares Held
11,437
+1408.8% QoQ
Ownership
0.409%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#8
of 12 holders
Holding Since
Sep 2025
2 quarters on record
Voting authority Sole 0% Shared 0% None 100%

Common Shares in PCSA Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

StoneX Group Inc. holds $4,702,554 across 49 Biotechnology names. PCSA ranks #27 (0.5% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 2,066 $1,026,244
2 REGN
Regeneron Pharmaceuticals, Inc.
 891 $555,574
3 PRAX
Praxis Precision Medicines, Inc.
 1,521 $509,215
4 HALO
Halozyme Therapeutics, Inc.
 5,845 $457,488
5 HRMY
Harmony Biosciences Holdings, Inc.
 12,149 $442,345
6 BBIO
BridgeBio Pharma, Inc.
 3,888 $289,578
7 CRSP
CRISPR Therapeutics AG
 4,133 $225,413
8 REPL
Replimune Group, Inc.
 10,770 $119,223

All Filings in PCSA

Export CSV
2 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $21,959 11,437
2025-09-30 $3,638 18,951